NOKOMIS, Fla.--(BUSINESS WIRE)--Rainbow BioSciences, LLC, the biotech subsidiary of Rainbow Coral Corp. (RBCC), today announced the collaboration of its latest target, Amarantus BioSciences, Inc. (OTCBB: AMBS), with Brewer Sports International (BSI) to increase awareness about new medical therapies in development to effectively treat traumatic brain injuries, commonly referred to as concussions, occurring primarily as a result of football and other contact sports.
